Mostrar el registro sencillo

dc.contributor.authorSánchez Gaya, Víctores_ES
dc.contributor.authorRada Iglesias, Álvaro es_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-10-16T15:22:12Z
dc.date.available2023-10-16T15:22:12Z
dc.date.issued2023es_ES
dc.identifier.issn0305-1048es_ES
dc.identifier.issn1362-4962es_ES
dc.identifier.urihttps://hdl.handle.net/10902/30211
dc.description.abstractUnderstanding the pathological impact of non-coding genetic variation is a major challenge in medical genetics. Accumulating evidences indicate that a significant fraction of genetic alterations, including structural variants (SVs), can cause human disease by altering the function of non-coding regulatory elements, such as enhancers. In the case of SVs, described pathomechanisms include changes in enhancer dosage and long-range enhancer-gene communication. However, there is still a clear gap between the need to predict and interpret the medical impact of non-coding variants, and the existence of tools to properly perform these tasks. To reduce this gap, we have developed POSTRE (Prediction Of STRuctural variant Effects), a computational tool to predict the pathogenicity of SVs implicated in a broad range of human congenital disorders. By considering disease-relevant cellular contexts, POSTRE identifies SVs with either coding or long-range pathological consequences with high specificity and sensitivity. Furthermore, POSTRE not only identifies pathogenic SVs, but also predicts the disease-causative genes and the underlying pathological mechanism (e.g, gene deletion, enhancer disconnection, enhancer adoption, etc.). POSTRE is available at https://github.com/vicsanga/Postre.es_ES
dc.description.sponsorshipFunding: Víctor Sánchez-Gaya is supported by a doctoral fellow-ship from the University of Cantabria (Spain); Work in the Rada-Iglesias laboratory is supported by the EMBO Young Investigator Programme [PGC2018- 095301-B-I00, PID2021-123030NB-I00] funded by MCIN/AEI/10.13039/501 100 011 033 and by ‘ERDF A way of making Europe’ [RED2018-102553-T (REDE-VNEURAL 3.0)] funded by MCIN/AEI/10.13039/501 100 011 033; ERC CoG ‘PoisedLogic’ [862 022] funded by the European Research Council and grant ‘ENHPATHY’ H2020-MSCA-ITN-2019-860002 funded by the European Commission. Funding for open access charge: Grants. Conflict of interest statement. None declared. Acknowledgements: We would like to thank Maria Mariner Fauli for her advice on POSTRE’s graphical design and help with the elaboration of some figures. We would also like to thank Magdalena Laugsch, Julia Baptista, Ayat Essabi, Judith Zaugg and all the Rada-Iglesias lab members for insightful comments and suggestions.es_ES
dc.format.extent27 p.es_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rights© The Author(s) 2023es_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.sourceNucleic Acids Research, 2023, 51(9), e54es_ES
dc.titlePOSTRE: a tool to predict the pathological effects of human structural variantses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1093/nar/gkad225es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution-NonCommercial 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial 4.0 International